{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T22:10:18Z","timestamp":1741903818193,"version":"3.38.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.annder.2024.103339","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T05:18:53Z","timestamp":1738214333000},"page":"103339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lentiginous macules appearing in resolving psoriatic plaques after treatment with interleukin-23 inhibitors: A case series"],"prefix":"10.1016","volume":"152","author":[{"given":"A.","family":"Pourteau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Teillet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Sylvain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Golinvaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Masson Regnault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2024.103339_b0005","article-title":"Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis","volume":"1 2","author":"Sbidian","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.annder.2024.103339_b0010","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/jdv.16926","article-title":"EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 2: specific clinical and comorbid situations","volume":"35","author":"Nast","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2024.103339_b0015","first-page":"7079","article-title":"Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature","volume":"9","author":"Mar\u00eda","year":"2017","journal-title":"Dermatol Reports"},{"key":"10.1016\/j.annder.2024.103339_b0020","doi-asserted-by":"crossref","first-page":"15048","DOI":"10.1111\/dth.15048","article-title":"Secukinumab-induced multiple lentigines in areas of resolved psoriatic plaques: A case report and literature review","volume":"34","author":"Zhang","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.annder.2024.103339_b0025","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jdcr.2018.07.021","article-title":"Eruptive lentiginosis in resolving psoriatic plaques","volume":"4","author":"Micieli","year":"2018","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.annder.2024.103339_b0030","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3109\/15569527.2014.959664","article-title":"Multiple lentigines confined to psoriatic plaques induced by biologic agents in psoriasis therapy: a case and review of the literature","volume":"34","author":"Dogan","year":"2015","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.annder.2024.103339_b0035","doi-asserted-by":"crossref","first-page":"15468","DOI":"10.1111\/dth.15468","article-title":"Persistent eruptive lentiginosis in a psoriatic patient after 4-year effective treatment with ustekinumab","volume":"35","author":"Parietti","year":"2022","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.annder.2024.103339_b0040","doi-asserted-by":"crossref","DOI":"10.5070\/D3251042619","article-title":"Appearance of lentigines in psoriasis patient treated with guselkumab","volume":"25","author":"Lee","year":"2019","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.annder.2024.103339_b0045","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1007\/s10067-022-06276-y","article-title":"Eruptive lentigines confined to psoriatic plaques following biologic therapy","volume":"41","author":"Khanna","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.annder.2024.103339_b0050","doi-asserted-by":"crossref","first-page":"13483","DOI":"10.1111\/srt.13483","article-title":"Eruptive lentiginosis in resolving plaque psoriasis during treatment with risankizumab","volume":"29","author":"Palmisano","year":"2023","journal-title":"Skin Res Technol"},{"key":"10.1016\/j.annder.2024.103339_b0055","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/j.1365-2133.2006.07189.x","article-title":"Induction of eruptive benign melanocytic naevi by immune suppressive agents, including biologicals","volume":"154","author":"Bovenschen","year":"2006","journal-title":"Br J Dermatol mai"},{"key":"10.1016\/j.annder.2024.103339_b0060","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/17425255.2017.1247155","article-title":"Drug-induced eruptive melanocytic nevi","volume":"13","author":"Vena","year":"2017","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.annder.2024.103339_b0065","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1038\/jid.2013.237","article-title":"IL-17 and TNF synergistically modulate cytokine expression while suppressing melanogenesis: potential relevance to psoriasis","volume":"133","author":"Wang","year":"2013","journal-title":"J Invest Dermatol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963824000954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963824000954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T21:31:42Z","timestamp":1741901502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963824000954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0151963824000954"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2024.103339","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lentiginous macules appearing in resolving psoriatic plaques after treatment with interleukin-23 inhibitors: A case series","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2024.103339","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103339"}}